Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for rifamycin B (compound)
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- Broad Connectivity Map (CMAP 2.0) compound database
- B-cell lymphoma cell lines treated by 92 FDA approved compounds - a timecourse
- Liver Pharmacology and Xenobiotic Response Repertoire
Most Relevant Literature
- Differential mass spectrometry-based proteome analyses unveil major regulatory hubs in rifamycin B p…
- Amycolatopsis mediterranei: A Sixty-Year Journey from Strain Isolation to Unlocking Its Potential of…
- Whole genome sequence of the rifamycin B-producing strain Amycolatopsis mediterranei S699.
- Development of balanced medium composition for improved rifamycin B production by isolated Amycolato…
- Comparative genomics revealed key molecular targets to rapidly convert a reference rifamycin-produci…
Most Relevant Clinical Trials
- Rifamycin SV-MMX® 400 mg b.i.d. vs. Rifamycin SV-MMX® 600 mg t.i.d. vs. Placebo in Acute Uncomplicat…
- Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D
- Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea
- Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children…
- A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone…
